Adult Multipotent Stromal Cell Technology for Bone Regeneration: A Review

Veterinary Surgery

Volumn 42, Issue 1, 2013, Pages 1-11

  Lopez, Mandi J ^a   Daigle, Patrick R ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ANIMAL DISEASE; ARTICLE; BONE DEVELOPMENT; METHODOLOGY; MULTIPOTENT STEM CELL; PHYSIOLOGY; STEM CELL TRANSPLANTATION; TRANSPLANTATION;

ANIMALS; BONE DEVELOPMENT; MULTIPOTENT STEM CELLS; OSTEOGENESIS; STEM CELL TRANSPLANTATION; TISSUE AND ORGAN HARVESTING;

EQUIDAE;

EID: 84871933066     PISSN: 01613499     EISSN: 1532950X     Source Type: Journal    
DOI: 10.1111/j.1532-950X.2012.01077.x     Document Type: Article

References (145)

1. Dominici M, Le BK, Mueller I, et al: Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006;8:315-317
2. Bruder SP, Jaiswal N, Haynesworth SE: Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem 1997;64:278-294
3. Kadiyala S, Young RG, Thiede MA, et al: Culture expanded canine mesenchymal stem cells possess osteochondrogenic potential in vivo and in vitro. Cell Transplant 1997;6:125-134
4. Bosch P, Musgrave DS, Lee JY, et al: Osteoprogenitor cells within skeletal muscle. J Orthop Res 2000;18:933-944
5. Young HE, Steele TA, Bray RA, et al: Human reserve pluripotent mesenchymal stem cells are present in the connective tissues of skeletal muscle and dermis derived from fetal, adult, and geriatric donors. Anat Rec 2001;264:51-62
6. Spencer ND, Gimble JM, Lopez MJ: Mesenchymal stromal cells: past, present, and future. Vet Surg 2011;40:129-139
7. Friedenstein AJ, Chailakhjan RK, Lalykina KS: The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 1970;3:393-403
8. Noel D, Caton D, Roche S, et al: Cell specific differences between human adipose-derived and mesenchymal-stromal cells despite similar differentiation potentials. Exp Cell Res 2008;314:1575-1584
9. Pittenger MF, Mackay AM, Beck SC, et al: Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-147
10. Simmons PJ, Torok-Storb B: Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1. Blood 1991;78:55-62
11. Haynesworth SE, Baber MA, Caplan AI: Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies. Bone 1992;13:69-80
12. Martinez C, Hofmann TJ, Marino R, et al: Human bone marrow mesenchymal stromal cells express the neural ganglioside GD2: a novel surface marker for the identification of MSCs. Blood 2007;109:4245-4248
13. Caplan AI: Mesenchymal stem cells. J Orthop Res 1991;9:641-650
14. Horwitz EM, Keating A: Nonhematopoietic mesenchymal stem cells: what are they? Cytotherapy 2000;2:387-388
15. Horwitz EM, Le BK, Dominici M, et al: Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy 2005;7:393-395
16. Nakahara H, Goldberg VM, Caplan AI: Culture-expanded human periosteal-derived cells exhibit osteochondral potential in vivo. J Orthop Res 1991;9:465-476
17. Wickham MQ, Erickson GR, Gimble JM, et al: Multipotent stromal cells derived from the infrapatellar fat pad of the knee. Clin Orthop Relat Res 2003;196-212
18. De Bari C, Dell'Accio F, Tylzanowski P, et al: Multipotent mesenchymal stem cells from adult human synovial membrane. Arthritis Rheum 2001;44:1928-1942
19. Hennrick KT, Keeton AG, Nanua S, et al: Lung cells from neonates show a mesenchymal stem cell phenotype. Am J Respir Crit Care Med 2007;175:1158-1164
20. Miura M, Gronthos S, Zhao M, et al: SHED: stem cells from human exfoliated deciduous teeth. Proc Natl Acad Sci U S A 2003;100:5807-5812
21. Hoynowski SM, Fry MM, Gardner BM, et al: Characterization and differentiation of equine umbilical cord-derived matrix cells. Biochem Biophys Res Commun 2007;362:347-353
22. Zvaifler NJ, Marinova-Mutafchieva L, Adams G, et al: Mesenchymal precursor cells in the blood of normal individuals. Arthritis Res 2000;2:477-488
23. Brighton CT, Lorich DG, Kupcha R, et al: The pericyte as a possible osteoblast progenitor cell. Clin Orthop Relat Res 1992;275:287-299
24. Staszkiewicz J, Frazier TP, Rowan BG, et al: Cell growth characteristics, differentiation frequency, and immunophenotype of adult ear mesenchymal stem cells. Stem Cells Dev 2010;19:83-92
25. Cui Q, Ming XZ, Balian G, et al: Comparison of lumbar spine fusion using mixed and cloned marrow cells. Spine (Phila Pa 1976) 2001;26:2305-2310
26. Kim MS, Kim SK, Kim SH, et al: In vivo osteogenic differentiation of rat bone marrow stromal cells in thermosensitive MPEG-PCL diblock copolymer gels. Tissue Eng 2006;12:2863-2873
27. Braccini A, Wendt D, Farhadi J, et al: The osteogenicity of implanted engineered bone constructs is related to the density of clonogenic bone marrow stromal cells. J Tissue Eng Regen Med 2007;1:60-65
28. Cowan CM, Shi YY, Aalami OO, et al: Adipose-derived adult stromal cells heal critical-size mouse calvarial defects. Nat Biotechnol 2004;22:560-567
29. Di Bella C, Farlie P, Penington AJ: Bone regeneration in a rabbit critical-sized skull defect using autologous adipose-derived cells. Tissue Eng Part A 2008;14:483-490
30. Degano IR, Vilalta M, Bago JR, et al: Bioluminescence imaging of calvarial bone repair using bone marrow and adipose tissue-derived mesenchymal stem cells. Biomaterials 2008;29:427-437
31. Bruder SP, Kraus KH, Goldberg VM, et al: The effect of implants loaded with autologous mesenchymal stem cells on the healing of canine segmental bone defects. J Bone Joint Surg Am 1998;80:985-996
32. Martin DR, Cox NR, Hathcock TL, et al: Isolation and characterization of multipotential mesenchymal stem cells from feline bone marrow. Exp Hematol 2002;30:879-886
33. Huang JI, Durbhakula MM, Angele P, et al: Lunate arthroplasty with autologous mesenchymal stem cells in a rabbit model. J Bone Joint Surg Am 2006;88:744-752
34. Maniatopoulos C, Sodek J, Melcher AH: Bone formation in vitro by stromal cells obtained from bone marrow of young adult rats. Cell Tissue Res 1988;254:317-330
35. Dennis JE, Merriam A, Awadallah A, et al: A quadripotential mesenchymal progenitor cell isolated from the marrow of an adult mouse. J Bone Miner Res 1999;14:700-709
36. Izadpanah R, Joswig T, Tsien F, et al: Characterization of multipotent mesenchymal stem cells from the bone marrow of rhesus macaques. Stem Cells Dev 2005;14:440-451
37. Fortier LA, Nixon AJ, Williams J, et al: Isolation and chondrocytic differentiation of equine bone marrow-derived mesenchymal stem cells. Am J Vet Res 1998;59:1182-1187
38. Osyczka AM, Damek-Poprawa M, Wojtowicz A, et al: Age and skeletal sites affect BMP-2 responsiveness of human bone marrow stromal cells. Connect Tissue Res 2009;50:270-277
39. Rodbell M: The metabolism of isolated fat cells. IV. Regulation of release of protein by lipolytic hormones and insulin. J Biol Chem 1966;241:3909-3917
40. Rodbell M: Metabolism of isolated fat cells. II. The similar effects of phospholipase C (Clostridium perfringens alpha toxin) and of insulin on glucose and amino acid metabolism. J Biol Chem 1966;241:130-139
41. Rodbell M, Jones AB: Metabolism of isolated fat cells. 3. The similar inhibitory action of phospholipase C (Clostridium perfringens alpha toxin) and of insulin on lipolysis stimulated by lipolytic hormones and theophylline. J Biol Chem 1966;241:140-142
42. Lacasa D, Agli B, Giudicelli Y: Zeta PKC in rat preadipocytes: modulation by insulin and serum mitogenic factors and possible role in adipogenesis. Biochem Biophys Res Commun 1995;217:123-130
43. Tchkonia T, Tchoukalova YD, Giorgadze N, et al: Abundance of two human preadipocyte subtypes with distinct capacities for replication, adipogenesis, and apoptosis varies among fat depots. Am J Physiol Endocrinol Metab 2005;288:E267-E277
44. Neupane M, Chang CC, Kiupel M, et al: Isolation and characterization of canine adipose-derived mesenchymal stem cells. Tissue Eng Part A 2008;14:1007-1015
45. Huggins CB: The formation of bone under the influence of epithelium of the urinary tract. Arch Surg 1931;22:377-408
46. Friedenstein AJ: Osteogenetic activity of transplanted transitional epithelium. Acta Anat (Basel) 1961;45:31-59
47. Castro-Malaspina H, Gay RE, Resnick G, et al: Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. Blood 1980;56:289-301
48. Phinney DG, Kopen G, Righter W, et al: Donor variation in the growth properties and osteogenic potential of human marrow stromal cells. J Cell Biochem 1999;75:424-436
49. Vidal MA, Kilroy GE, Lopez MJ, et al: Characterization of equine adipose tissue-derived stromal cells: adipogenic and osteogenic capacity and comparison with bone marrow-derived mesenchymal stromal cells. Vet Surg 2007;36:613-622
50. Zvonic S, Ptitsyn AA, Kilroy G, et al: Circadian oscillation of gene expression in murine calvarial bone. J Bone Miner Res 2007;22:357-365
51. Yadav VK, Ryu JH, Suda N, et al: Lrp5 controls bone formation by inhibiting serotonin synthesis in the duodenum. Cell 2008;135:825-837
52. Baksh D, Boland GM, Tuan RS: Cross-talk between Wnt signaling pathways in human mesenchymal stem cells leads to functional antagonism during osteogenic differentiation. J Cell Biochem 2007;101:1109-1124
53. Bhat BM, Robinson JA, Coleburn VE, et al: Evidence of in vivo osteoinduction in adult rat bone by adeno-Runx2 intra-femoral delivery. J Cell Biochem 2008;103:1912-1924
54. Gronthos S, Chen S, Wang CY, et al: Telomerase accelerates osteogenesis of bone marrow stromal stem cells by upregulation of CBFA1, osterix, and osteocalcin. J Bone Miner Res 2003;18:716-722
55. Liu Q, Cen L, Yin S, et al: A comparative study of proliferation and osteogenic differentiation of adipose-derived stem cells on akermanite and beta-TCP ceramics. Biomaterials 2008;29:4792-4799
56. Kruyt MC, Wilson CE, de Bruijn JD, et al: The effect of cell-based bone tissue engineering in a goat transverse process model. Biomaterials 2006;27:5099-5106
57. Scott MA, Levi B, Askarinam A, et al: Brief review of models of ectopic bone formation. Stem Cells Dev 2012;21:655-667
58. Bauer TW, Muschler GF: Bone graft materials. An overview of the basic science. Clin Orthop Relat Res 2000;371:10-27
59. Southwood LL, Frisbie DD, Kawcak CE, et al: Evaluation of Ad-BMP-2 for enhancing fracture healing in an infected defect fracture rabbit model. J Orthop Res 2004;22:66-72
60. Mastrogiacomo M, Papadimitropoulos A, Cedola A, et al: Engineering of bone using bone marrow stromal cells and a silicon-stabilized tricalcium phosphate bioceramic: evidence for a coupling between bone formation and scaffold resorption. Biomaterials 2007;28:1376-1384
61. Coombes AG, Meikle MC: Resorbable synthetic polymers as replacements for bone graft. Clin Mater 1994;17:35-67
62. Roy TD, Simon JL, Ricci JL, et al: Performance of degradable composite bone repair products made via three-dimensional fabrication techniques. J Biomed Mater Res A 2003;66:283-291
63. Meaney DF: Mechanical properties of implantable biomaterials. Clin Podiatr Med Surg 1995;12:363-384
64. Park HK, Dujovny M, Agner C, et al: Biomechanical properties of calvarium prosthesis. Neurol Res 2001;23:267-276
65. Kirker-Head CA: Recombinant bone morphogenetic proteins: novel substances for enhancing bone healing. Vet Surg 1995;24:408-419
66. Dard M, Sewing A, Meyer J, et al: Tools for tissue engineering of mineralized oral structures. Clin Oral Investig 2000;4:126-129
67. Lee SJ: Cytokine delivery and tissue engineering. Yonsei Med J 2000;41:704-719
68. Karageorgiou V, Kaplan D: Porosity of 3D biomaterial scaffolds and osteogenesis. Biomaterials 2005;26:5474-5491
69. Hulbert SF, Young FA, Mathews RS, et al: Potential of ceramic materials as permanently implantable skeletal prostheses. J Biomed Mater Res 1970;4:433-456
70. Story BJ, Wagner WR, Gaisser DM, et al: In vivo performance of a modified CSTi dental implant coating. Int J Oral Maxillofac Implants 1998;13:749-757
71. Bjerre L, Bunger CE, Kassem M, et al: Flow perfusion culture of human mesenchymal stem cells on silicate-substituted tricalcium phosphate scaffolds. Biomaterials 2008;29:2616-2627
72. Brayfield CA, Marra KG, Leonard JP, et al: Excimer laser channel creation in polyethersulfone hollow fibers for compartmentalized in vitro neuronal cell culture scaffolds. Acta Biomater 2008;4:244-255
73. Buxton AN, Zhu J, Marchant R, et al: Design and characterization of poly(ethylene glycol) photopolymerizable semi-interpenetrating networks for chondrogenesis of human mesenchymal stem cells. Tissue Eng 2007;13:2549-2560
74. Ashammakhi N, Ndreu A, Piras AM, et al: Biodegradable nanomats produced by electrospinning: expanding multifunctionality and potential for tissue engineering. J Nanosci Nanotechnol 2007;7:862-882
75. Badami AS, Kreke MR, Thompson MS, et al: Effect of fiber diameter on spreading, proliferation, and differentiation of osteoblastic cells on electrospun poly(lactic acid) substrates. Biomaterials 2006;27:596-606
76. Ishaug-Riley SL, Crane-Kruger GM, Yaszemski MJ, et al: Three-dimensional culture of rat calvarial osteoblasts in porous biodegradable polymers. Biomaterials 1998;19:1405-1412
77. Chen R, Chen H, Han J, et al: Manufacture and study of porous poly(l-lactic acid) (PLLA)/beta-tricalcium phosphate (beta-TCP) composite. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 2001;18:177-180
78. Gomes ME, Ribeiro AS, Malafaya PB, et al: A new approach based on injection moulding to produce biodegradable starch-based polymeric scaffolds: morphology, mechanical and degradation behaviour. Biomaterials 2001;22:883-889
79. Burg KJ, Delnomdedieu M, Beiler RJ, et al: Application of magnetic resonance microscopy to tissue engineering: a polylactide model. J Biomed Mater Res 2002;61:380-390
80. Awad HA, Wickham MQ, Leddy HA, et al: Chondrogenic differentiation of adipose-derived adult stem cells in agarose, alginate, and gelatin scaffolds. Biomaterials 2004;25:3211-3222
81. Holtorf HL, Jansen JA, Mikos AG: Flow perfusion culture induces the osteoblastic differentiation of marrow stroma cell-scaffold constructs in the absence of dexamethasone. J Biomed Mater Res A 2005;72:326-334
82. Causa F, Netti PA, Ambrosio L, et al: Poly-epsilon-caprolactone/hydroxyapatite composites for bone regeneration: in vitro characterization and human osteoblast response. J Biomed Mater Res A 2006;76:151-162
83. Beier JP, Stern-Straeter J, Foerster VT, et al: Tissue engineering of injectable muscle: three-dimensional myoblast-fibrin injection in the syngeneic rat animal model. Plast Reconstr Surg 2006;118:1113-1121
84. Beattie AJ, Gilbert TW, Guyot JP, et al: Chemoattraction of progenitor cells by remodeling extracellular matrix scaffolds. Tissue Eng Part A 2009;15:1119-1125
85. Badylak SF, Park K, Peppas N, et al: Marrow-derived cells populate scaffolds composed of xenogeneic extracellular matrix. Exp Hematol 2001;29:1310-1318
86. Hing KA, Wilson LF, Buckland T: Comparative performance of three ceramic bone graft substitutes. Spine J 2007;7:475-490
87. Petite H, Viateau V, Bensaid W, et al: Tissue-engineered bone regeneration. Nat Biotechnol 2000;18:959-963
88. Groeneveld EH, Van Den Bergh JP, Holzmann P, et al: Mineralization processes in demineralized bone matrix grafts in human maxillary sinus floor elevations. J Biomed Mater Res 1999;48:393-402
89. Dimitriou R, Tsiridis E, Giannoudis PV: Current concepts of molecular aspects of bone healing. Injury 2005;36:1392-1404
90. Dallari D, Fini M, Stagni C, et al: In vivo study on the healing of bone defects treated with bone marrow stromal cells, platelet-rich plasma, and freeze-dried bone allografts, alone and in combination. J Orthop Res 2006;24:877-888
91. Peng CA, Palsson BO: Determination of specific oxygen uptake rates in human hematopoietic cultures and implications for bioreactor design. Ann Biomed Eng 1996;24:373-381
92. Cancedda R, Giannoni P, Mastrogiacomo M: A tissue engineering approach to bone repair in large animal models and in clinical practice. Biomaterials 2007;28:4240-4250
93. Janssen FW, Hofland I, van OA, et al: Online measurement of oxygen consumption by goat bone marrow stromal cells in a combined cell-seeding and proliferation perfusion bioreactor. J Biomed Mater Res A 2006;79:338-348
94. Wang Y, Uemura T, Dong J, et al: Application of perfusion culture system improves in vitro and in vivo osteogenesis of bone marrow-derived osteoblastic cells in porous ceramic materials. Tissue Eng 2003;9:1205-1214
95. Schliephake H, Zghoul N, Jager V, et al: Effect of seeding technique and scaffold material on bone formation in tissue-engineered constructs. J Biomed Mater Res A 2009;90:429-437
96. Du D, Furukawa K, Ushida T: Oscillatory perfusion seeding and culturing of osteoblast-like cells on porous beta-tricalcium phosphate scaffolds. J Biomed Mater Res A 2008;86:796-803
97. McIntosh K, Zvonic S, Garrett S, et al: The immunogenicity of human adipose-derived cells: temporal changes in vitro. Stem Cells 2006;24:1246-1253
98. Yanez R, Lamana ML, Garcia-Castro J, et al: Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease. Stem Cells 2006;24:2582-2591
99. Fang B, Song Y, Liao L, et al: Favorable response to human adipose tissue-derived mesenchymal stem cells in steroid-refractory acute graft-versus-host disease. Transplant Proc 2007;39:3358-3362
100. Quarto R, Mastrogiacomo M, Cancedda R, et al: Repair of large bone defects with the use of autologous bone marrow stromal cells. N Engl J Med 2001;344:385-386
101. Caplan AI: Osteogenesis imperfecta, rehabilitation medicine, fundamental research and mesenchymal stem cells. Connect Tissue Res 1995;31:S9-S14
102. Kawai T, Anada T, Masuda T, et al: The effect of synthetic octacalcium phosphate in a collagen scaffold on the osteogenicity of mesenchymal stem cells. Eur Cell Mater 2011;22:124-136
103. Gomide VS, Zonari A, Ocarino NM, et al: In vitro and in vivo osteogenic potential of bioactive glass-PVA hybrid scaffolds colonized by mesenchymal stem cells. Biomed Mater 2012;7:015004. doi: 10.1088/1748-6041/7/1/015004
104. Lopez MJ, McIntosh KR, Spencer ND, et al: Acceleration of spinal fusion using syngeneic and allogeneic adult adipose derived stem cells in a rat model. J Orthop Res 2009;27:366-373
105. Mastrogiacomo M, Corsi A, Francioso E, et al: Reconstruction of extensive long bone defects in sheep using resorbable bioceramics based on silicon stabilized tricalcium phosphate. Tissue Eng 2006;12:1261-1273
106. Yuan J, Cui L, Zhang WJ, et al: Repair of canine mandibular bone defects with bone marrow stromal cells and porous beta-tricalcium phosphate. Biomaterials 2007;28:1005-1013
107. Kraus KH, Kirker-Head C: Mesenchymal stem cells and bone regeneration. Vet Surg 2006;35:232-242
108. Ito K, Yamada Y, Naiki T, et al: Simultaneous implant placement and bone regeneration around dental implants using tissue-engineered bone with fibrin glue, mesenchymal stem cells and platelet-rich plasma. Clin Oral Implants Res 2006;17:579-586
109. Zheng Y, Liu Y, Zhang CM, et al: Stem cells from deciduous tooth repair mandibular defect in swine. J Dent Res 2009;88:249-254
110. Haig DM, Thomson J, Percival A: The in-vitro detection and quantitation of ovine bone marrow precursors of multipotential colony-forming cells. J Comp Pathol 1994;111:73-85
111. Kruyt MC, Dhert WJ, Oner FC, et al: Analysis of ectopic and orthotopic bone formation in cell-based tissue-engineered constructs in goats. Biomaterials 2007;28:1798-1805
112. Kruyt MC, Dhert WJ, Yuan H, et al: Bone tissue engineering in a critical size defect compared to ectopic implantations in the goat. J Orthop Res 2004;22:544-551
113. Kruyt MC, van Gaalen SM, Oner FC, et al: Bone tissue engineering and spinal fusion: the potential of hybrid constructs by combining osteoprogenitor cells and scaffolds. Biomaterials 2004;25:1463-1473
114. Kon E, Muraglia A, Corsi A, et al: Autologous bone marrow stromal cells loaded onto porous hydroxyapatite ceramic accelerate bone repair in critical-size defects of sheep long bones. J Biomed Mater Res 2000;49:328-337
115. Bensaid W, Oudina K, Viateau V, et al: De novo reconstruction of functional bone by tissue engineering in the metatarsal sheep model. Tissue Eng 2005;11:814-824
116. Zhu L, Liu W, Cui L, et al: Tissue-engineered bone repair of goat-femur defects with osteogenically induced bone marrow stromal cells. Tissue Eng 2006;12:423-433
117. Scott M: Musculoskeletal injuries in nonracing quarter horses. Vet Clin North Am Equine Pract 2008;24:133-152
118. Richardson DW: Complications of orthopaedic surgery in horses. Vet Clin North Am Equine Pract 2008;24:591-610, viii
119. Kapur S, Baylink DJ, Lau KH: Fluid flow shear stress stimulates human osteoblast proliferation and differentiation through multiple interacting and competing signal transduction pathways. Bone 2003;32:241-251
120. Arnhold SJ, Goletz I, Klein H, et al: Isolation and characterization of bone marrow-derived equine mesenchymal stem cells. Am J Vet Res 2007;68:1095-1105
121. Giovannini S, Brehm W, Mainil-Varlet P, et al: Multilineage differentiation potential of equine blood-derived fibroblast-like cells. Differentiation 2008;76:118-129
122. Koerner J, Nesic D, Romero JD, et al: Equine peripheral blood-derived progenitors in comparison to bone marrow-derived mesenchymal stem cells. Stem Cells 2006;24:1613-1619
123. Richardson LE, Dudhia J, Clegg PD, et al: Stem cells in veterinary medicine: attempts at regenerating equine tendon after injury. Trends Biotechnol 2007;25:409-416
124. Vidal MA, Kilroy GE, Johnson JR, et al: Cell growth characteristics and differentiation frequency of adherent equine bone marrow-derived mesenchymal stromal cells: adipogenic and osteogenic capacity. Vet Surg 2006;35:601-610
125. Toupadakis CA, Wong A, Genetos DC, et al: Comparison of the osteogenic potential of equine mesenchymal stem cells from bone marrow, adipose tissue, umbilical cord blood, and umbilical cord tissue. Am J Vet Res 2010;71:1237-1245
126. Frisbie DD, Smith RK: Clinical update on the use of mesenchymal stem cells in equine orthopaedics. Equine Vet J 2010;42:86-89
127. Braun J, Hack A, Weis-Klemm M, et al: Evaluation of the osteogenic and chondrogenic differentiation capacities of equine adipose tissue-derived mesenchymal stem cells. Am J Vet Res 2010;71:1228-1236
128. Mambelli LI, Santos EJ, Frazao PJ, et al: Characterization of equine adipose tissue-derived progenitor cells before and after cryopreservation. Tissue Eng Part C Methods 2009;15:87-94
129. Radcliffe CH, Flaminio MJ, Fortier LA: Temporal analysis of equine bone marrow aspirate during establishment of putative mesenchymal progenitor cell populations. Stem Cells Dev 2010;19:269-282
130. Penny J, Harris P, Shakesheff KM, et al: The biology of equine mesenchymal stem cells: phenotypic characterization, cell surface markers and multilineage differentiation. Front Biosci 2012;17:892-908
131. Raabe O, Shell K, Wurtz A, et al: Further insights into the characterization of equine adipose tissue-derived mesenchymal stem cells. Vet Res Commun 2011;35:355-365
132. Loh YH, Wu Q, Chew JL, et al: The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat Genet 2006;38:431-440
133. Li X, Zhou SG, Imreh MP, et al: Horse embryonic stem cell lines from the proliferation of inner cell mass cells. Stem Cells Dev 2006;15:523-531
134. Reed SA, Johnson SE: Equine umbilical cord blood contains a population of stem cells that express Oct4 and differentiate into mesodermal and endodermal cell types. J Cell Physiol 2008;215:329-336
135. Violini S, Ramelli P, Pisani LF, et al: Horse bone marrow mesenchymal stem cells express embryo stem cell markers and show the ability for tenogenic differentiation by in vitro exposure to BMP-12. BMC Cell Biol 2009;10:29. doi:10.1186/1471-2121-10-29
136. de Mattos CA, Alves AL, Golim MA, et al: Isolation and immunophenotypic characterization of mesenchymal stem cells derived from equine species adipose tissue. Vet Immunol Immunopathol 2009;132:303-306
137. Martinello T, Bronzini I, Maccatrozzo L, et al: Cryopreservation does not affect the stem characteristics of multipotent cells isolated from equine peripheral blood. Tissue Eng Part C Methods 2010;16:771-781
138. Wilke MM, Nydam DV, Nixon AJ: Enhanced early chondrogenesis in articular defects following arthroscopic mesenchymal stem cell implantation in an equine model. J Orthop Res 2007;25:913-925
139. Kisiday JD, Kopesky PW, Evans CH, et al: Evaluation of adult equine bone marrow- and adipose-derived progenitor cell chondrogenesis in hydrogel cultures. J Orthop Res 2008;26:322-331
140. Koch TG, Berg LC, Betts DH: Current and future regenerative medicine: principles, concepts, and therapeutic use of stem cell therapy and tissue engineering in equine medicine. Can Vet J 2009;50:155-165
141. Guest DJ, Smith MR, Allen WR: Equine embryonic stem-like cells and mesenchymal stromal cells have different survival rates and migration patterns following their injection into damaged superficial digital flexor tendon. Equine Vet J 2010;42:636-642
142. Seo JP, Tsuzuki N, Haneda S, et al: Proliferation of equine bone marrow-derived mesenchymal stem cells in gelatin/beta-tricalcium phosphate sponges. Res Vet Sci 2012;93:1481-1486
143. Ishihara A, Zekas LJ, Litsky AS, et al: Dermal fibroblast-mediated BMP2 therapy to accelerate bone healing in an equine osteotomy model. J Orthop Res 2010;28:403-411
144. Cheung WK, Working DM, Galuppo LD, et al: Osteogenic comparison of expanded and uncultured adipose stromal cells. Cytotherapy 2010;12:554-562
145. Venugopal J, Rajeswari R, Shayanti M, et al: Electrosprayed hydroxyapatite on polymer nanofibers to differentiate mesenchymal stem cells to osteogenesis. J Biomater Sci Polym Ed 2012. doi: 11.1163/156856212X629845